Sofia, N.; Mühlebach, S.; Musazzi, U.M.; Khatib, R.; Martinez Sesmero, J.M.; Lipp, H.-P.; Surugue, J.; Di Francesco, T.; Flühmann, B.
How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries. Pharmaceutics 2021, 13, 1010.
https://doi.org/10.3390/pharmaceutics13071010
AMA Style
Sofia N, Mühlebach S, Musazzi UM, Khatib R, Martinez Sesmero JM, Lipp H-P, Surugue J, Di Francesco T, Flühmann B.
How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries. Pharmaceutics. 2021; 13(7):1010.
https://doi.org/10.3390/pharmaceutics13071010
Chicago/Turabian Style
Sofia, Natalia, Stefan Mühlebach, Umberto M. Musazzi, Rani Khatib, José Manuel Martinez Sesmero, Hans-Peter Lipp, Jacqueline Surugue, Tiziana Di Francesco, and Beat Flühmann.
2021. "How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries" Pharmaceutics 13, no. 7: 1010.
https://doi.org/10.3390/pharmaceutics13071010
APA Style
Sofia, N., Mühlebach, S., Musazzi, U. M., Khatib, R., Martinez Sesmero, J. M., Lipp, H. -P., Surugue, J., Di Francesco, T., & Flühmann, B.
(2021). How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries. Pharmaceutics, 13(7), 1010.
https://doi.org/10.3390/pharmaceutics13071010
